In the News
Variants of vitamin D receptor linked to increased risk of breast cancer
Thursday, April 17, 2008
Genetic variations in the body’s receptor for vitamin D could increase the risk of breast cancer in postmenopausal women, according to a study published today in the open access journal Breast Cancer Research. Jenny Chang-Claude of the Division of Cancer Epidemiology, at the German Cancer Research Center, in Heidelberg, and colleagues there and at the Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Germany, undertook a population-based case-control study involving 1,408 patients and 2,612 control individuals.… continue reading
Vitamin D found to guard against artery disease
Thursday, April 17, 2008
By Will Dunham
WASHINGTON (Reuters) – Vitamin D may protect against an artery disease in which fatty deposits restrict blood flow to the limbs, researchers said on Wednesday. Scientists at the Albert Einstein College of Medicine of Yeshiva University in New York found that people with low levels of vitamin D in their blood experience an increased risk for a condition known as peripheral artery disease, or PAD.… continue reading
Fibromyalgia and Vitamin D
Thursday, April 17, 2008
There are many people who suffer from fibromyalgia who have not taken a simple blood test to measure the level of vitamin D in their system. This is a shame because low levels of vitamin D may contribute greatly to the symptoms of this disease.… continue reading
Low-calorie diet may help stave off skin cancer
Thursday, April 17, 2008
Eating fewer calories appears to inhibit the development of precancerous skin conditions, U.S. researchers have discovered, possibly showing that a low-calorie diet can play a big role in preventing skin cancer. The study, which looked only at mice, showed that the consumption of fewer calories prevented the activation of two signalling pathways connected to the growth and development of cancer.… continue reading
The perils of halting cancer medication trials
Wednesday, April 16, 2008
PAUL TAYLOR
Cancer patients could be put at risk by new medications that are rushed to market before they are fully studied, a team of European researchers warns. The researchers say they are disturbed by a growing trend of cancer studies being halted early after promising preliminary results suggest the experimental drugs are helping patients.… continue reading